---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-24-001431"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2024-09-17T23:59:59+00:00"
generated_at: "2026-05-31T04:14:40.967840+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Renovaro receives Nasdaq deficiency notice for bid price below $1; 180-day cure period

## Summary
- Nasdaq notified Renovaro on Sept 12, 2024 that stock failed minimum $1 bid price for 30 consecutive business days.
- Company has 180 calendar days (until March 11, 2025) to regain compliance by closing at or above $1 for 10 consecutive days.
- If not cured, Renovaro may qualify for an additional 180-day period by meeting other listing standards.
- Stock continues trading under symbol RENB; company is evaluating options to regain bid price compliance.

## SEC filing metadata
- accession: 0001731122-24-001431
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2024-09-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112224001431/0001731122-24-001431-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112224001431/e5942_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-24-001431
- JSON: https://secwatch.observer/filing/0001731122-24-001431.json
- Plain text: https://secwatch.observer/filing/0001731122-24-001431.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.